Piramal Pharma Limited (BOM:543635)

Piramal Pharma Statistics

Total Valuation

Piramal Pharma has a market cap or net worth of INR 291.49 billion. The enterprise value is 335.27 billion.

Market Cap	291.49B
Enterprise Value	335.27B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+8.30%
Shares Change (QoQ)	-7.69%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	607.58M

Valuation Ratios

The trailing PE ratio is 749.34.

PE Ratio	749.34
Forward PE	n/a
PS Ratio	3.26
PB Ratio	3.69
P/TBV Ratio	7.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	861.88
EV / Sales	3.75
EV / EBITDA	22.69
EV / EBIT	46.74
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.61
Debt / EBITDA	3.40
Debt / FCF	n/a
Interest Coverage	1.51

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	3.24%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	13.32M
Profits Per Employee	57,896
Employee Count	6,719
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+55.09%
50-Day Moving Average	212.33
200-Day Moving Average	220.37
Relative Strength Index (RSI)	50.77
Average Volume (20 Days)	264,016

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Piramal Pharma had revenue of INR 89.49 billion and earned 389.00 million in profits. Earnings per share was 0.29.

Revenue	89.49B
Gross Profit	53.51B
Operating Income	6.48B
Pretax Income	3.69B
Net Income	389.00M
EBITDA	13.71B
EBIT	6.48B
Earnings Per Share (EPS)	0.29

Balance Sheet

The company has 4.08 billion in cash and 47.86 billion in debt, giving a net cash position of -43.78 billion.

Cash & Cash Equivalents	4.08B
Total Debt	47.86B
Net Cash	-43.78B
Net Cash Per Share	n/a
Equity (Book Value)	79.07B
Book Value Per Share	59.51
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 59.79%, with operating and profit margins of 7.25% and 0.43%.

Gross Margin	59.79%
Operating Margin	7.25%
Pretax Margin	4.13%
Profit Margin	0.43%
EBITDA Margin	15.32%
EBIT Margin	7.25%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.05%.

Dividend Per Share	0.11
Dividend Yield	0.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-8.30%
Shareholder Yield	-8.25%
Earnings Yield	0.13%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a